These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1795436)

  • 61. Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation.
    Labeur C; Lambert G; Van Cauteren T; Duverger N; Vanloo B; Chambaz J; Vandekerckhove J; Castro G; Rosseneu M
    Atherosclerosis; 1998 Aug; 139(2):351-62. PubMed ID: 9712342
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lipoprotein composition and HDL particle size distribution in women with non-insulin-dependent diabetes mellitus and the effects of probucol treatment.
    Lane JT; Subbaiah PV; Otto ME; Bagdade JD
    J Lab Clin Med; 1991 Aug; 118(2):120-8. PubMed ID: 1856575
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency.
    Noto H; Kawamura M; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K
    Atherosclerosis; 2003 Nov; 171(1):131-6. PubMed ID: 14642415
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differential effect of ultracentrifugation on apolipoprotein A-I-containing lipoprotein subpopulations.
    Cheung MC; Wolf AC
    J Lipid Res; 1988 Jan; 29(1):15-25. PubMed ID: 3128619
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Apolipoprotein A-I containing lipoproteins in coronary artery disease.
    Puchois P; Kandoussi A; Fievet P; Fourrier JL; Bertrand M; Koren E; Fruchart JC
    Atherosclerosis; 1987 Nov; 68(1-2):35-40. PubMed ID: 3120739
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates.
    Parra HJ; Mezdour H; Ghalim N; Bard JM; Fruchart JC
    Clin Chem; 1990 Aug; 36(8 Pt 1):1431-5. PubMed ID: 2117505
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The effects of probucol on the levels, structure, composition and metabolism of plasma lipoprotein in rats.
    Eisenberg S
    Biochim Biophys Acta; 1993 Mar; 1167(1):79-84. PubMed ID: 8461336
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity.
    Magill P; Rao SN; Miller NE; Nicoll A; Brunzell J; St Hilaire J; Lewis B
    Eur J Clin Invest; 1982 Apr; 12(2):113-20. PubMed ID: 6807682
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cell lipid metabolism modulators 2-bromopalmitate, D609, monensin, U18666A and probucol shift discoidal HDL formation to the smaller-sized particles: implications for the mechanism of HDL assembly.
    Quach D; Vitali C; La FM; Xiao AX; Millar JS; Tang C; Rader DJ; Phillips MC; Lyssenko NN
    Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1968-1979. PubMed ID: 27671775
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Apolipoprotein modulation of streptococcal serum opacity factor activity against human plasma high-density lipoproteins.
    Rosales C; Gillard BK; Courtney HS; Blanco-Vaca F; Pownall HJ
    Biochemistry; 2009 Aug; 48(33):8070-6. PubMed ID: 19618959
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
    Schonfeld G; Witztum J; Basich P
    Artery; 1982; 10(2):99-104. PubMed ID: 7092583
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Changes in the distribution and composition of high-density lipoproteins in primary hypothyroidism.
    Muls E; Rosseneu M; Lamberigts G; De Moor P
    Metabolism; 1985 Apr; 34(4):345-53. PubMed ID: 3920475
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protein transfer between A-I-containing lipoprotein subpopulations: evidence of non-transferable A-I in particles with A-II.
    Cheung MC; Wolf AC; Knopp RH; Foster DM
    Biochim Biophys Acta; 1992 Nov; 1165(1):68-77. PubMed ID: 1420350
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Precipitation procedures used to isolate high density lipoprotein with particular reference to effects on apo A-I-only particles and lipoprotein(a).
    Vallance DT; Byrne DJ; Winder AF
    Clin Chim Acta; 1994 Sep; 229(1-2):77-85. PubMed ID: 7988057
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency.
    Tilly-Kiesi M; Packard CJ; Kahri J; Ehnholm C; Shepherd J; Taskinen MR
    Atherosclerosis; 1997 Feb; 128(2):213-22. PubMed ID: 9050778
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multivariate genetic analysis of high density lipoprotein particles.
    Steinmetz J; Boerwinkle E; Gueguen R; Visvikis S; Henny J; Siest G
    Atherosclerosis; 1992 Feb; 92(2-3):219-27. PubMed ID: 1385955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.